Why is Aarti Pharma falling/rising?

As of 05-Jun, Aarti Pharmalabs Ltd is experiencing a decline in its stock price, currently at Rs. 921.40, which reflects a decrease of Rs. 10.4 or 1.12%. Despite this drop, the stock has shown strong performance over the past week, gaining 2.04%, and has significantly outperformed the market over the last month and year, with returns of 30.65% and 59.65%, respectively. Today's price summary indicates that the stock hit a new 52-week high of Rs. 948.8 earlier in the day but has since underperformed its sector by 2.18%. The stock's technical indicators remain bullish, trading above all major moving averages, and there has been a notable increase in investor participation, with delivery volume rising by 61.21% against the 5-day average. However, the recent trend reversal after two consecutive days of gains suggests some volatility.
In the broader market context, Aarti Pharmalabs' short-term performance has been favorable compared to the benchmark, as it has outperformed the Sensex, which has seen a slight decline of 0.23% over the past week. While the company demonstrates strong financial metrics, such as a low Debt to EBITDA ratio and impressive growth in profit after tax, there are concerns regarding long-term growth potential due to modest net sales growth and a decrease in institutional investor participation. This decline in institutional stakes, which fell by 4.11% in the last quarter, may impact market confidence and contribute to the stock's current price movement.